Sant Pau Memory Unit
“Excellence in care, research and innovation
in neurodegenerative diseases.”
+500
PUBLICATIONS
+60
RESEARCHERS
+20
YEARS OF RESEARCH
+300
INTERNATIONAL COLLABORATIONS
OUR RESEARCH ⬈
CLINICAL TRIALS ⬈
The unique composition of the Sant Pau Memory Unit has favored the development of translational research lines that combine clinical observation, direct contact with the people treated and their families, and basic research in the laboratory.
Our Memory Unit treats more than 2000 patients each year and is made up of a multidisciplinary team of professionals that includes specialists in neurology, neuropsychology, biology, engineering, laboratory technicians and research nursing staff. This multidisciplinary structure, unique in the State and exceptional in Europe, allows us to combine clinical and laboratory studies, positioning our team as a benchmark in the treatment and research of Alzheimer’s disease.
The Sant Pau Memory Unit of the Neurology Department at Hospital de la Santa Creu i Sant Pau in Barcelona is a multidisciplinary team dedicated to the assistance and research in Alzheimer and other neurodegenerative diseases.
Digital cognitive assessment and blood biomarkers: two complementary perspectives for assessing Alzheimer’s disease
Digital cognitive assessment and blood biomarkers: two complementary perspectives for assessing Alzheimer’s disease Blood-based biomarkers are making it easier to detect biological changes associated with Alzheimer’s disease through a simple blood test. However, on...
We welcome our new team members!💙
Welcome to the Memory Unit! We continue growing and adding talent to our team. We welcome our new team members and the professionals joining our Memory Unit during this period of training and collaboration. New team members Marc Sans ↗ Visiting health...
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome–associated Alzheimer’s disease
White matter alterations are commonly observed in Alzheimer’s disease (AD) and reflect a convergence of several pathological processes, including myelin loss, axonal degeneration, and microvascular injury. Peak width of skeletonized mean diffusivity (PSMD) is a...
